Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate

An ophthalmic pharmaceutical composition comprising as active ingredient a combination of:

• a) glycine and proline;
• and
• b) sodium hyaluronate
• wherein glycine, L-proline and sodium hyaluronate are comprised within the following percentage ranges by weight:
• glycine:
• 0.01 to 0.5%;
• L-proline:
• 0.06 to 0.09%;
• and
• sodium hyaluronate:
• 0.1 to 0.5%.